Safety of balloon- vs self-expandable TAVR valves, effects of aleglitazar and metformin after ACS in patients with DM, management of fibromyalgia, and more.

JAMA Editor’s Summary

Safety of balloon- vs self-expandable TAVR valves, effects of aleglitazar and metformin after ACS in patients with DM, management of fibromyalgia, and more.

Editor's Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 16, 2014 issue

April 15, 2014

Listen on your favorite player Take me to this show’s page

Newer →

Neurology Theme Issue

← Older

Spotlight on the new ACC/AHA lipid and JNC8 hypertension guidelines, EGFR inhibitors vs chemotherapy for NSCLC, and more.

Facebook Twitter Buffer LinkedIn WhatsApp

Safety of balloon- vs self-expandable TAVR valves, effects of aleglitazar and metformin after ACS in patients with DM, management of fibromyalgia, and more.

Editor’s Audio Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the April 16, 2014 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00